Marion Thomas Charisma, Jamil Husam
General Medicine, Mid Yorkshire Teaching NHS (National Health Service) Trust, Wakefield, GBR.
Acute Internal Medicine, Mid Yorkshire Teaching NHS (National Health Service) Trust, Wakefield, GBR.
Cureus. 2024 Sep 27;16(9):e70341. doi: 10.7759/cureus.70341. eCollection 2024 Sep.
This clinical case report explores the occurrence of acute thrombocytopenia following teicoplanin infusion in a patient with diabetic foot osteomyelitis. The patient, a 54-year-old male with a medical history of chronic kidney disease, hypertension, and type II diabetes mellitus, experienced a severe drop in platelet count during teicoplanin treatment. The article discusses the clinical presentation, diagnostic assessments, and management of teicoplanin-induced thrombocytopenia. Additionally, it delves into the broader context of drug-induced thrombocytopenia and emphasizes the importance of a systematic approach to understanding and managing this adverse reaction.
本临床病例报告探讨了一名糖尿病足骨髓炎患者在输注替考拉宁后发生急性血小板减少症的情况。该患者为一名54岁男性,有慢性肾病、高血压和II型糖尿病病史,在替考拉宁治疗期间血小板计数严重下降。本文讨论了替考拉宁诱导的血小板减少症的临床表现、诊断评估和管理。此外,还深入探讨了药物性血小板减少症的更广泛背景,并强调了采用系统方法理解和管理这种不良反应的重要性。